Basis: Trailing twelve months (TTM net income over the latest quarterly balance sheet). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on assets (ROA) high or low?
The return on assets (ROA) of -8.01% is 89% above its 4-year average of -74.07%, near the high end of its 4-year range (-215.33%–-0.01%).
78.77% above its 12-month average of -37.73%.
Reported quarterly return on assets; no daily interpolation. Q2 FY2025 (2025-12-31): 0.00%.
RETURN ON ASSETS (ROA)
-8.01%
RETURN ON ASSETS (ROA) AVG TTM
-37.73%
RETURN ON ASSETS (ROA) AVG 3Y
-92.58%
RETURN ON ASSETS (ROA) AVG 5Y
N/A
RETURN ON ASSETS (ROA) AVG 10Y
N/A
RETURN ON ASSETS (ROA) AVG 15Y
N/A
RETURN ON ASSETS (ROA) AVG 20Y
N/A
CURRENT VS TTM AVG
+78.77%
CURRENT VS 3Y AVG
+91.35%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.48%
median of 784 covered companies
CURRENT VS SECTOR MEDIAN
+74.55%
vs the sector median at left
Moolec Science S.A.
Market Cap
$3.57M
Return on Assets (ROA)
-8.01%
TTM Avg
-37.73%
3Y Avg
-92.58%
5Y Avg
N/A
Market Cap
$3.49M
Return on Assets (ROA)
-19.43%
TTM Avg
-90.07%
3Y Avg
-138.72%
5Y Avg
-110.42%
Market Cap
$3.29M
Return on Assets (ROA)
-206.55%
TTM Avg
-205.58%
3Y Avg
-343.02%
5Y Avg
-343.02%
Market Cap
$3.29M
Return on Assets (ROA)
-111.26%
TTM Avg
-147.41%
3Y Avg
-127.90%
5Y Avg
-106.52%
Market Cap
$3.51M
Return on Assets (ROA)
-299.21%
TTM Avg
-178.76%
3Y Avg
-127.09%
5Y Avg
-697.98%
Market Cap
$3.23M
Return on Assets (ROA)
-34.54%
TTM Avg
-27.85%
3Y Avg
-120.45%
5Y Avg
-88.60%
Market Cap
$3.23M
Return on Assets (ROA)
-80.08%
TTM Avg
-84.48%
3Y Avg
-250.02%
5Y Avg
-187.49%
Market Cap
$3.21M
Return on Assets (ROA)
55.30%
TTM Avg
-3307.76%
3Y Avg
-1681.95%
5Y Avg
-1351.74%
| NAME | MARKET CAP | RETURN ON ASSETS (ROA) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moolec Science S.A. (MLEC) | $3.57M | -8.01% | -37.73% | -92.58% | N/A |
| Eocene Ltd. (EOCN)vs › | $3.49M | N/A | N/A | N/A | N/A |
| Mustang Bio, Inc. (MBIO)vs › | $3.49M | -19.43% | -90.07% | -138.72% | -110.42% |
| Cadrenal Therapeutics, Inc. Common Stock (CVKD)vs › | $3.29M | -206.55% | -205.58% | -343.02% | -343.02% |
| Aethlon Medical, Inc. (AEMD)vs › | $3.29M | -111.26% | -147.41% | -127.90% | -106.52% |
| Nexalin Technology, Inc. (NXL)vs › | $3.51M | -299.21% | -178.76% | -127.09% | -697.98% |
| Paranovus Entertainment Technology Ltd. (PAVS)vs › | $3.23M | -34.54% | -27.85% | -120.45% | -88.60% |
| Adagio Medical Holdings, Inc. (ADGM)vs › | $3.23M | -80.08% | -84.48% | -250.02% | -187.49% |
| MBody AI Ltd. (MBAI)vs › | $3.21M | 55.30% | -3307.76% | -1681.95% | -1351.74% |
| IceCure Medical Ltd (ICCM)vs › | $3.13M | -95.33% | -115.11% | -93.94% | -73.81% |
ROA
-8.0%
ROE
-89.8%
ROA = Net Income / Total Assets
Return on assets measures how efficiently a company generates profit from its total assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON ASSETS (ROA) |
|---|---|
| 2025-06-30 | -54.45% |
| 2024-06-30 | -21.02% |
| 2023-06-30 | -215.33% |
| 2022-06-30 | -79.53% |
| 2021-06-30 | -0.01% |
